Adding equipment will not solve a production delay caused by crowded staging space, unclear material status, or conflicting movement routes. A GMP material flow assessment examines how materials actually move through a facility and where those movements create waiting, mixup risks, or contamination concerns.
For pharmaceutical manufacturers and CDMOs, the starting point is the full operating sequence, not simply the floor plan. Use this practical review before a layout change, product introduction, or capacity expansion. Adapt it to your processes and applicable requirements.
1. Map actual movement, including the return trips
Follow a representative batch from receiving through storage, dispensing, production, packaging, and dispatch as applicable. Include samples, unused materials, waste, cleaning supplies, and equipment moving back for cleaning or storage. Map personnel routes alongside material routes.
Observe the work across relevant shifts rather than relying only on the intended procedure. Record where materials wait, who transfers them, and how status is confirmed at each handoff. A route that works during quiet hours may become congested when several activities overlap.
2. Check the layout against the control needs
For finished pharmaceuticals, 21 CFR 211.42 requires suitable facilities, adequate space for orderly placement of equipment and materials, and material flow designed to prevent contamination. It also addresses separate or defined areas, or other control systems, for specified operations to prevent contamination or mixups.
This does not mean that every facility needs the same layout. Assess the controls needed for your products and operations. Sterile processing, hazardous materials, and specialized products may require additional technical review beyond this general checklist.
- Can incoming materials be held without obstructing released stock?
- Are rejected, returned, or unidentified items controlled?
- Can staff distinguish clean equipment from equipment awaiting cleaning?
- Do movement routes create avoidable contact between incompatible activities?
- Is there room for cleaning, inspection, and maintenance around stored items and equipment?
3. Make material status visible and traceable
Review how physical labels, inventory records, and approved procedures agree. Under 21 CFR 211.80, components and drug product containers and closures require written handling procedures, contamination prevention, lot identification, and appropriate status identification.
In practice, challenge the handoffs: can the receiving operator, warehouse team, and production user all determine the correct lot and whether it is available for use? Identify who resolves mismatches between a label and the system record. Do not rely on familiarity with a pallet’s location as proof of its status.
4. Test the busiest realistic operating scenario
Review simultaneous activities, not just a single batch. Include deliveries, material preparation, production, cleaning, waste removal, and maintenance access. For a CDMO, define the proposed project mix and document assumptions about future work rather than treating unknown projects as automatically compatible.
Use the review to identify staging capacity, route conflicts, and the timing of shared spaces. A hypothetical example is a cart prepared for one batch blocking access needed to remove another batch’s waste. The assessment should identify a controlled solution before that conflict becomes routine.
5. Compare improvements before committing to construction
Possible actions include better scheduling, defined staging locations, revised transfer procedures, material kitting, or equipment relocation. Evaluate each option with manufacturing, Quality, facilities, and safety personnel. Do not assume that moving a cabinet or marking a floor requires no change assessment.
For each proposed change, record the risk addressed, owner, required approvals, and evidence needed before use. Consider impacts on utilities, cleaning access, environmental controls, qualification, and emergency access where relevant.
6. Verify the revised flow in operation
Agree on checks before implementation. These may include transfer waiting time, blocked access observations, status discrepancies, and adherence to approved routes. Review results across representative activity levels and investigate unintended effects.
The useful deliverable is an annotated flow map and prioritized action plan, supported by documented assumptions and agreed acceptance criteria. It should show what the team will change and how they will know the change works.
Discuss your facility flow constraints
PharmExcel’s manufacturing optimization and facility readiness services support practical assessments and implementation planning. Request a consultation with Rob Braddock to discuss material handoffs, space constraints, or an upcoming facility change.